SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is drawing attention after a recent rebound that traders say held its gains, with bullish technical setups and positioning ahead of earnings. The upbeat view contrasts with concerns that high rates and a sluggish housing market could continue to weigh on renovation demand.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers sharp rally to fresh multi-year highs is drawing attention, with traders citing rotation into defensive, dividend-paying pharma stocks and positioning ahead of the quarterly report. Bulls see a technical breakout and pipeline momentum, while skeptics warn the move may meet resistance and point to patent-expiration and growth concerns.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 77,397.34014094 USD and is up 0.28 over the last 24 hours. It is currently trading on 12773 active market(s) with $12,152,377,915.37 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoin is drawing attention amid concerns over Binances reported major hack and paused withdrawals, with traders debating whether damaged exchange trust could trigger further selling. Others argue the market is absorbing the shock and point to Binances reported reimbursement progress and planned withdrawal reopening as reasons for optimism.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Attention centers on expected Q3 results and the Phase 3 QUILT-2.005 topline for ANKTIVA plus BCG in BCG-naive bladder cancer; the trial is database-locked, with a supplemental filing planned if results support it. Bullish traders see the readout and ANKTIVAs expanded bladder-cancer label as growth catalysts, while others question commercial uptake and point to competition, short-selling, and broader market weakness to explain the volatility.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders use the leveraged inverse Nasdaq ETF to hedge or bet on further weakness in tech, citing concerns about AI spending and valuations alongside recent tech-led selling. The community is divided: some expect more downside, while others warn that rumors of a U.S.Iran deal and a possible market rebound could reverse gains in the short ETF.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow is being discussed amid volatile, uneven trading across major indexes, with traders watching Fed policy and rising Treasury yields as pressures on equities. Some see relative strength in the Dow as money rotates away from tech, while others warn that inflation, oil-market risks and weakening momentum could deepen a selloff.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Discussion centers on BioCrysts upcoming quarterly results and whether continued ORLADEYO growth can support the stock despite its weak performance. Traders are also looking ahead to Navenibart and Netherton data, while debating managements acquisition strategy and expressing frustration over dilution and limited shareholder returns; buyout talk remains speculative.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results and outlook are drawing attention, with traders highlighting stronger streaming profitability and resilient theme-park performance. The reaction is mixed: some see support for a turnaround, while others point to the stocks persistent range-bound price action and difficulty holding gains.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention ahead of its upcoming earnings report, with traders watching whether guidance holds and how management addresses pressure on the pharmacy benefit management business. Some see the recent pullback as a potential technical rebound setup, while others remain cautious after the stocks recent selling.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

A sharp volatility spike has lifted UVIX, drawing traders seeking a hedge against a broader market pullback. The community is split between expecting volatility to persistciting concerns about oil, interest rates and geopolitical risksand warning that UVIX can quickly lose value as volatility fades and its leveraged futures exposure decays.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Toll Brothers (TOL) Outpaced the Stock Market Today

Toll Brothers (TOL) concluded the recent trading session at $141.95, signifying a +1.1% move from its prior day's close.

Is Trending Stock Toll Brothers Inc. (TOL) a Buy Now?

Recently, Zacks.com users have been paying close attention to Toll Brothers (TOL). This makes it worthwhile to examine what the stock has in store.

Here's How Much You Would Have Made Owning Toll Brothers Stock In The Last 5 Years

Toll Brothers (NYSE:TOL) has outperformed the market over the past 5 years by 6.4% on an annualized basis producing an average annual return of 17.43%. Currently, Toll Brothers has a market capitalization of $12.08read more...

Here are Friday's biggest analyst calls: Nvidia, SpaceX, Tesla, Apple, Mobileye, EchoStar, Toll Brothers & more

Here are Friday's biggest calls on Wall Street...

Toll Brothers Inc. (TOL) is Attracting Investor Attention: Here is What You Should Know  

Toll Brothers (TOL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

$1000 Invested In Toll Brothers 10 Years Ago Would Be Worth This Much Today

Toll Brothers (NYSE:TOL) has outperformed the market over the past 10 years by 2.78% on an annualized basis producing an average annual return of 16.59%. Currently, Toll Brothers has a market capitalization of $12.42read more...

US Real Estate Stocks Hit All-Time Low Relative To S&P 500, Prompting Peter Schiff’s ‘Industry Is Dead’ Warning 

Equity

Weak housing demand and shifting investor preferences pressure the sector. 


This Toll Brothers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with price targets of $70, $159, $42, $55 and $30.read more...

Here are Thursday's biggest analyst calls: Nvidia, Apple, Netflix, Micron, Amazon, Meta, Toll Brothers & more

Here are Thursday's biggest calls on Wall Street...

Toll Brothers Inc. (TOL) Is a Trending Stock: Facts to Know Before Betting on It

Toll Brothers, Inc. engages in the design, building, marketing, and arranging of financing for detached and attached homes in residential communities. It operates through the following geographical segments: North Region, Mid-Atlantic Region, South Region, Mountain Region, and Pacific Region. The North region segment includes Connecticut, Delaware, Massachusetts, Michigan, New Jersey, New York, and Pennsylvania. The Mid-Atlantic region segment consists of Georgia, Maryland, North Carolina, Tennessee, and Virginia. The South region segment includes Florida, South Carolina, and Texas. The Mountain region segment consists of Arizona, Colorado, Idaho, Nevada, and Utah. The Pacific region segment includes California, Oregon, and Washington. The company was founded by Robert I. Toll, and Bruce E. Toll in May 1967 and is headquartered in Fort Washington, PA.

Toll Brothers Inc.

Bearish Sentiment

<ul class="summary-bullets"><li>Charlie Bilello said U.S. real estate stocks have fallen to their lowest level ever compared with the S&amp;P 500.&nbsp;</li><li>Peter Schiff warned that the sector could fall further as higher mortgage rates hurt the industry.&nbsp;</li><li>Higher interest rates have hurt real estate by raising borrowing costs, weakening housing demand and pressuring commercial properties.&nbsp;</li></ul>US real estate stocks have sunk to their weakest level ever relative to the S&amp;P 500, wiping out all the outperformance they built during the early-to-mid 2000s housing bubble, according to Creative Planning's Charlie Bilello. Economist Peter Schiff warns the slide is far from over and calls the industry dead.&nbsp;The milestone matters because it suggests investors may be seeing a long-term shift rather than a temporary slowdown. The 10-year Treasury yield is near its highest level in 25 years, while mortgage rates are nearing 8%, reversing the low-rate support that helped the housing market for years.&nbsp;<h2 class="st-heading-2">Real Estate Stocks Hit Record Low&nbsp;</h2>Bilello, Chief Market Strategist at Creative Planning, flagged the extreme in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/charliebilello/status/2107185783132340316">post</a> on X.“US real estate stocks are now at their lowest level ever relative to the S&amp;P 500, erasing all of their relative outperformance from the early-to-mid 2000s housing bubble.”&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/housing_a1be8b6ea7.jpg" alt="housing.jpg" width="900" height="581"><figcaption>Source: Charlie Bilello’s X Post</figcaption></figure>The chart shows that the&nbsp;<a href="https://stocktwits.com/symbol/IYR">iShares US Real Estate ETF</a> (IYR) to&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF Trust</a> (SPY) ratio fell to a record low of 0.122 on Oct. 5. It had reached 0.525 in February 2007 during the housing boom before the Great Financial Crisis. Since then, real estate stocks have generally lagged the broader market despite occasional rallies.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261006_020256021_0881b52db7.png" alt="koyfin_20261006_020256021.png" width="2400" height="1240"></figure>Schiff, an economist and longtime market bear,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/PeterSchiff/status/2107221474193105115">replied</a> bluntly: "Plus they are going a lot lower from here. The industry is dead. It lived by ever falling mortgage rates and government subsidies. It's now dying by reversal of the same dynamics."&nbsp;<h2 class="st-heading-2">Housing Affordability Crisis Hits Real Estate&nbsp;</h2>Schiff’s comments highlight a major change in interest rates and Federal Reserve policy. After the 2008 financial crisis, low borrowing costs helped boost REIT values, real estate deals and homebuilder profits. Now, higher 10-year Treasury yields have raised borrowing costs and made REIT dividends less attractive to investors.&nbsp;High mortgage rates are hurting housing demand and home sales, while commercial real estate faces lower property values and refinancing pressure. Investors are also moving money into safer Treasuries and technology stocks, cutting demand for real estate.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261006_015930573_3f1dd3713a.png" alt="koyfin_20261006_015930573.png" width="2400" height="1240"></figure>Last week, Morgan Stanley put out a mixed outlook on major U.S. homebuilders. The firm is bullish on Toll Brothers (TOL), giving it an ‘Overweight’ rating and $159 price target, citing wealthy buyers, pricing power and attractive valuation. PulteGroup (PHG) and D.R. Horton (DHI) received ‘Equal Weight’ ratings, with $128 and $151 price targets, respectively, as affordability concerns limit their upside. Lennar (LEN) received an ‘Underweight’ rating and a $65 price target due to incentives, higher lot costs, and weak first-time buyer demand.&nbsp;So far this year, DHI, PHM, and LEN stocks are down 2% to 27%, while TOL is up 0.1%.Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/the-big-short-investor-michael-burry-justifies-lululemon-tax-loss-sale-i-am-not-throwing-in-the-towel/cZDstsERBk4">‘The Big Short’ Investor Michael Burry Justifies Lululemon Tax-Loss Sale: ‘I Am Not Throwing In The Towel’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Montage Laguna Beach resort is shown at sunset in Laguna Beach, CA.

US real estate stocks have sunk to their weakest level ever relative to the S&P 500, wiping out all the outperformance they built during the early-to-mid 2000s housing bubble, according to Creative Planning's Charlie Bilello. Economist Peter Schiff warns 

US Real Estate Stocks Hit All-Time Low Relative To S&P 500, Prompting Peter Schiff’s ‘Industry Is Dead’ Warning

D.R. Horton Inc.

iShares US Real Estate ETF

Lennar Corp.

PulteGroup Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$145.95
Prev Close	$144.27
Open	$144.19
Dividend Yield	0.73%
50-Day Moving Average	$137.90
Beta	1.13
Avg. Volume	1.12M
PE Ratio	11.72

52-Week High	$168.36
52-Week Low	$123.15
Market Capitalization	$13.45B
EPS (Annual)	$13.49
Price to Book	1.58
Revenue Per Employee	$2.24M

Feed

News

Sentiment

Earnings

Fundamentals

Info

TOL Fundamentals